Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01638637 · ClinicalTrials.gov registry record
Prospective Collection of Female and Male Specimens for PANTHER® System Testing
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 1,492
- Enrollment target
NCT01638637 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 1,492 participants.
The verdict
NCT01638637 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 1,492 participants
- Enrollment target
Study Summary
The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs and male first-catch urine and urethral swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® System
Interventions
- DEVICE APTIMA Assays; PANTHER System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,492 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01638637
The ClinicalTrials.gov registry entry for NCT01638637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,492 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gen-Probe, Incorporated, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which APTIMA Assays; PANTHER System is the first listed.
NCT01638637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01638637 about?
NCT01638637 is a clinical study titled "Prospective Collection of Female and Male Specimens for PANTHER® System Testing". The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs and male first-catch urine and urethral swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® System
What is the current status of trial NCT01638637?
This trial is currently completed. The enrollment target is 1,492 participants. The study started on 2012-02. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01638637?
The interventions under investigation include: APTIMA Assays; PANTHER System (DEVICE).
Who is sponsoring clinical trial NCT01638637?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.